表紙
市場調查報告書

多項睡眠生理腦波儀檢查裝置的全球市場:2019年∼2023年

Polysomnography Devices Market by End-users and Geography - Global Forecast and Analysis 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 909639
出版日期 內容資訊 英文 141 Pages
訂單完成後即時交付
價格
Back to Top
多項睡眠生理腦波儀檢查裝置的全球市場:2019年∼2023年 Polysomnography Devices Market by End-users and Geography - Global Forecast and Analysis 2019-2023
出版日期: 2019年08月28日內容資訊: 英文 141 Pages
簡介

全球多項睡眠生理腦波儀檢查裝置市場,由於有利的償付方案,睡眠呼吸中止症,尤其是OSA(阻塞型睡眠呼吸中止症)的盛行率增加,多項睡眠生理腦波儀檢驗的優點等成為成長促進因素,在預測期間內預計將以約6%的年複合成長率擴大。但,有關多項睡眠生理腦波儀檢查裝置的替代品,嚴格的法律規範,產品的回收,睡眠呼吸中止症的一般認識的缺乏及醫療檢驗工程師不足等要素,可能妨礙在預測期間內多項睡眠生理腦波儀檢查裝置產業的成長。

本報告提供全球多項睡眠生理腦波儀檢查裝置市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 各終端用戶比較:市場規模及預測(2018年∼2023年)
  • 醫院
  • 睡眠診所與診斷研究所
  • ASC(門診外科中心)
  • 居家醫療
  • 市場機會:各終端用戶

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 多項睡眠生理腦波儀檢查裝置的進步
  • 選擇居家醫療和遠程醫療的患者增加
  • 新興市場的巨大的成長機會

第12章 業者情勢

  • 概要
  • 創造性破壞狀況

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Cleveland Medical Devices Inc.
  • Compumedics Ltd.
  • Koninklijke Philips NV
  • Natus Medical Inc.
  • Neurosoft
  • Neurovirtual
  • 日本光電
  • ResMed Inc.
  • SOMNOmedics GmbH
  • Vyaire Medical Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR31934

About this market

Technavio's polysomnography devices market analysis considers sales from hospitals, sleep clinics and diagnostic laboratories, ASCs, and homecare. Our analysis also considers the sales of polysomnography devices in Asia, Europe, North America, and ROW. In 2018, the hospitals' segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the availability of specialist doctors along with latest and advanced equipment will play a significant role in the hospitals' segment to maintain its market position. Also, our global polysomnography devices market report looks at factors such as favorable reimbursement scenario, increasing prevalence of sleep apnea, especially OSA, and benefits of polysomnography. However, alternatives of polysomnography devices, stringent regulatory framework, and product recall, and lack of public awareness about sleep apnea and shortage of medical lab technicians may hamper the growth of the polysomnography devices industry over the forecast period.

Overview

Increasing prevalence of sleep apnea, especially OSA

Sleep apnea is a sleep disorder wherein breathing stops and starts, leading to sleep disruption. The main types of sleep apnea include OSA, which occurs when the throat muscles relax too much to allow normal breathing; central sleep apnea (CSA), which occurs when the brain does not send proper signals to the muscles that control breathing; and complex sleep apnea syndrome (CompSAS), which basically takes place when a person has both OSA and CSA. The prevalence of OSA is increasing due to obesity and an increase in the geriatric population. This is also common among people with hypertension. The increasing prevalence of sleep apnea, especially OSA will lead to the expansion of the global polysomnography devices market at a CAGR of almost 6% during the forecast period.

Advances in polysomnography devices

Technological advances in diagnosis and management of sleep disorders reflect the huge scope of innovations in polysomnography devices. Wireless polysomnography devices are the latest trend. This is ideal for use in attended, remotely attended, and unattended sleep diagnosis. The feature in it enhances the mobility and comfort of the patient. The small size of the device ensures a higher level of comfort and efficiency for use in a home or an ambulatory set-up. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global polysomnography devices market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global polysomnography devices market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading polysomnography devices manufacturers, that include Cleveland Medical Devices Inc., Compumedics Ltd., Koninklijke Philips NV, Natus Medical Inc., Neurosoft, Neurovirtual, Nihon Kohden Corp., ResMed Inc., SOMNOmedics GmbH, Vyaire Medical Inc.

Also, the polysomnography devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals - Market size and forecast 2018-2023
  • Sleep clinics and diagnostic laboratories -
  • Market size and forecast 2018-2023
  • ASCs - Market size and forecast 2018-2023
  • Homecare - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Advances in polysomnography devices
  • Increasing adoption of home healthcare and telemedicine by patients
  • Immense growth opportunities in emerging markets

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Cleveland Medical Devices Inc.
  • Compumedics Ltd.
  • Koninklijke Philips NV
  • Natus Medical Inc.
  • Neurosoft
  • Neurovirtual
  • Nihon Kohden Corp.
  • ResMed Inc.
  • SOMNOmedics GmbH
  • Vyaire Medical Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Product overview
  • Exhibit 02: Global medical devices market
  • Exhibit 03: Segments of global medical devices market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: End-user - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Hospitals - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Hospitals - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Sleep clinics and diagnostic laboratories - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Sleep clinics and diagnostic laboratories - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: ASCs - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 25: ASCs - Year-over-year growth 2019-2023 (%)
  • Exhibit 26: Homecare - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 27: Homecare - Year-over-year growth 2019-2023 (%)
  • Exhibit 28: Market opportunity by end-user
  • Exhibit 29: Customer landscape
  • Exhibit 30: Market share by geography 2018-2023 (%)
  • Exhibit 31: Geographic comparison
  • Exhibit 32: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 39: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 40: Key leading countries
  • Exhibit 41: Market opportunity
  • Exhibit 42: Impact of drivers and challenges
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: Cleveland Medical Devices Inc. - Vendor overview
  • Exhibit 49: Cleveland Medical Devices Inc. - Organizational developments
  • Exhibit 50: Cleveland Medical Devices Inc. - Key offerings
  • Exhibit 51: Compumedics Ltd. - Vendor overview
  • Exhibit 52: Compumedics Ltd. - Business segments
  • Exhibit 53: Compumedics Ltd. - Organizational developments
  • Exhibit 54: Compumedics Ltd. - Segment focus
  • Exhibit 55: Compumedics Ltd. - Key offerings
  • Exhibit 56: Koninklijke Philips NV - Vendor overview
  • Exhibit 57: Koninklijke Philips NV - Business segments
  • Exhibit 58: Koninklijke Philips NV - Organizational developments
  • Exhibit 59: Koninklijke Philips NV - Geographic focus
  • Exhibit 60: Koninklijke Philips NV - Segment focus
  • Exhibit 61: Koninklijke Philips NV - Key offerings
  • Exhibit 62: Natus Medical Inc. - Vendor overview
  • Exhibit 63: Natus Medical Inc. - Organizational developments
  • Exhibit 64: Natus Medical Inc. - Geographic focus
  • Exhibit 65: Natus Medical Inc. - Key offerings
  • Exhibit 66: Neurosoft - Vendor overview
  • Exhibit 67: Neurosoft - Organizational developments
  • Exhibit 68: Neurosoft - Key offerings
  • Exhibit 69: Neurovirtual - Vendor overview
  • Exhibit 70: Neurovirtual - Organizational developments
  • Exhibit 71: Neurovirtual - Key offerings
  • Exhibit 72: Nihon Kohden Corp. - Vendor overview
  • Exhibit 73: Nihon Kohden Corp. - Organizational developments
  • Exhibit 74: Nihon Kohden Corp. - Geographic focus
  • Exhibit 75: Nihon Kohden Corp. - Key offerings
  • Exhibit 76: ResMed Inc. - Vendor overview
  • Exhibit 77: ResMed Inc. - Business segments
  • Exhibit 78: ResMed Inc. - Organizational developments
  • Exhibit 79: ResMed Inc. - Geographic focus
  • Exhibit 80: ResMed Inc. - Segment focus
  • Exhibit 81: ResMed Inc. - Key offerings
  • Exhibit 82: SOMNOmedics GmbH - Vendor overview
  • Exhibit 83: SOMNOmedics GmbH - Organizational developments
  • Exhibit 84: SOMNOmedics GmbH - Key offerings
  • Exhibit 85: Vyaire Medical Inc. - Vendor overview
  • Exhibit 86: Vyaire Medical Inc. - Organizational developments
  • Exhibit 87: Vyaire Medical Inc. - Key offerings
  • Exhibit 88: Validation techniques employed for market sizing
  • Exhibit 89: Definition of market positioning of vendors
Back to Top